
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Seven Years of Selective Genetic Screening Program and Follow-Up of Asymptomatic Carriers With Hereditary Transthyretin Amyloidosis in Bulgaria - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59B5D3925FC8533AB5D300375E5850.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontneurology">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024406/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Neurology">
<meta name="citation_title" content="Seven Years of Selective Genetic Screening Program and Follow-Up of Asymptomatic Carriers With Hereditary Transthyretin Amyloidosis in Bulgaria">
<meta name="citation_author" content="Teodora Chamova">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Mariana Gospodinova">
<meta name="citation_author_institution" content="Expert Center for Transthyretin Cardiac Amyloidosis, University Hospital “St Ivan Rilski”, Sofia, Bulgaria">
<meta name="citation_author" content="Ognian Asenov">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Tihomir Todorov">
<meta name="citation_author_institution" content="Independent Medico-Diagnostic Laboratory Genome Center “Bulgaria”, Sofia, Bulgaria">
<meta name="citation_author_institution" content="Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria">
<meta name="citation_author" content="Zornitsa Pavlova">
<meta name="citation_author_institution" content="Independent Medico-Diagnostic Laboratory Genome Center “Bulgaria”, Sofia, Bulgaria">
<meta name="citation_author_institution" content="Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria">
<meta name="citation_author_institution" content="Department of Medical Chemistry and Biochemistry, Medical University Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Andrey Kirov">
<meta name="citation_author_institution" content="Independent Medico-Diagnostic Laboratory Genome Center “Bulgaria”, Sofia, Bulgaria">
<meta name="citation_author_institution" content="Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria">
<meta name="citation_author" content="Sylvia Cherninkova">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Kristina Kastreva">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Ani Taneva">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Stanislava Blagoeva">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Sashka Zhelyazkova">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Plamen Antimov">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Kaloian Chobanov">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Albena Todorova">
<meta name="citation_author_institution" content="Independent Medico-Diagnostic Laboratory Genome Center “Bulgaria”, Sofia, Bulgaria">
<meta name="citation_author_institution" content="Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria">
<meta name="citation_author_institution" content="Department of Medical Chemistry and Biochemistry, Medical University Sofia, Sofia, Bulgaria">
<meta name="citation_author" content="Ivailo Tournev">
<meta name="citation_author_institution" content="Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria">
<meta name="citation_author_institution" content="Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria">
<meta name="citation_publication_date" content="2022 Apr 8">
<meta name="citation_volume" content="13">
<meta name="citation_firstpage" content="844595">
<meta name="citation_doi" content="10.3389/fneur.2022.844595">
<meta name="citation_pmid" content="35463150">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024406/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024406/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024406/pdf/fneur-13-844595.pdf">
<meta name="description" content="Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is a rare, autosomal-dominant (AD) multisystem disorder resulting from the extracellular deposition of amyloid fibrils formed by a destabilized mutant form of transthyretin (TTR), a transport ...">
<meta name="og:title" content="Seven Years of Selective Genetic Screening Program and Follow-Up of Asymptomatic Carriers With Hereditary Transthyretin Amyloidosis in Bulgaria">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is a rare, autosomal-dominant (AD) multisystem disorder resulting from the extracellular deposition of amyloid fibrils formed by a destabilized mutant form of transthyretin (TTR), a transport ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024406/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9024406">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fneur.2022.844595"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fneur-13-844595.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9024406%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9024406/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9024406/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024406/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontneurology.gif" alt="Frontiers in Neurology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Neurology" title="Link to Frontiers in Neurology" shape="default" href="http://frontiersin.org/neurology" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Neurol</button></div>. 2022 Apr 8;13:844595. doi: <a href="https://doi.org/10.3389/fneur.2022.844595" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fneur.2022.844595</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Neurol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Neurol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Neurol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Neurol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Seven Years of Selective Genetic Screening Program and Follow-Up of Asymptomatic Carriers With Hereditary Transthyretin Amyloidosis in Bulgaria</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chamova%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Teodora Chamova</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Teodora Chamova</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chamova%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Teodora Chamova</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gospodinova%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mariana Gospodinova</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mariana Gospodinova</span></h3>
<div class="p">
<sup>2</sup>Expert Center for Transthyretin Cardiac Amyloidosis, University Hospital “St Ivan Rilski”, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gospodinova%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariana Gospodinova</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Asenov%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Ognian Asenov</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Ognian Asenov</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Asenov%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Ognian Asenov</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Todorov%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Tihomir Todorov</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Tihomir Todorov</span></h3>
<div class="p">
<sup>3</sup>Independent Medico-Diagnostic Laboratory Genome Center “Bulgaria”, Sofia, Bulgaria</div>
<div class="p">
<sup>4</sup>Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Todorov%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tihomir Todorov</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pavlova%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Zornitsa Pavlova</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Zornitsa Pavlova</span></h3>
<div class="p">
<sup>3</sup>Independent Medico-Diagnostic Laboratory Genome Center “Bulgaria”, Sofia, Bulgaria</div>
<div class="p">
<sup>4</sup>Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria</div>
<div class="p">
<sup>5</sup>Department of Medical Chemistry and Biochemistry, Medical University Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pavlova%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zornitsa Pavlova</span></a>
</div>
</div>
<sup>3,</sup><sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirov%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Andrey Kirov</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Andrey Kirov</span></h3>
<div class="p">
<sup>3</sup>Independent Medico-Diagnostic Laboratory Genome Center “Bulgaria”, Sofia, Bulgaria</div>
<div class="p">
<sup>4</sup>Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirov%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andrey Kirov</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cherninkova%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Sylvia Cherninkova</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Sylvia Cherninkova</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cherninkova%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sylvia Cherninkova</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kastreva%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Kristina Kastreva</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Kristina Kastreva</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kastreva%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kristina Kastreva</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Taneva%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Ani Taneva</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Ani Taneva</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Taneva%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ani Taneva</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blagoeva%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Stanislava Blagoeva</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Stanislava Blagoeva</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blagoeva%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stanislava Blagoeva</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhelyazkova%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Sashka Zhelyazkova</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Sashka Zhelyazkova</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhelyazkova%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sashka Zhelyazkova</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Antimov%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Plamen Antimov</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Plamen Antimov</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Antimov%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Plamen Antimov</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chobanov%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Kaloian Chobanov</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Kaloian Chobanov</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chobanov%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kaloian Chobanov</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Todorova%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Albena Todorova</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Albena Todorova</span></h3>
<div class="p">
<sup>3</sup>Independent Medico-Diagnostic Laboratory Genome Center “Bulgaria”, Sofia, Bulgaria</div>
<div class="p">
<sup>4</sup>Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria</div>
<div class="p">
<sup>5</sup>Department of Medical Chemistry and Biochemistry, Medical University Sofia, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Todorova%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Albena Todorova</span></a>
</div>
</div>
<sup>3,</sup><sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tournev%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Ivailo Tournev</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Ivailo Tournev</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div class="p">
<sup>6</sup>Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tournev%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Ivailo Tournev</span></a>
</div>
</div>
<sup>1,</sup><sup>6</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, University Hospital “Alexandrovska”, Medical University-Sofia, Sofia, Bulgaria</div>
<div id="aff2">
<sup>2</sup>Expert Center for Transthyretin Cardiac Amyloidosis, University Hospital “St Ivan Rilski”, Sofia, Bulgaria</div>
<div id="aff3">
<sup>3</sup>Independent Medico-Diagnostic Laboratory Genome Center “Bulgaria”, Sofia, Bulgaria</div>
<div id="aff4">
<sup>4</sup>Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria</div>
<div id="aff5">
<sup>5</sup>Department of Medical Chemistry and Biochemistry, Medical University Sofia, Sofia, Bulgaria</div>
<div id="aff6">
<sup>6</sup>Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Yue Huang, Capital Medical University, China</p></div>
<div class="fn" id="fn2"><p>Reviewed by: Maria Rosário Almeida, Universidade Do Porto, Portugal; Joel N. Buxbaum, The Scripps Research Institute, United States; Ruxu Zhang, Central South University, China; Haruki Koike, Nagoya University, Japan; Giuseppe Vita, University of Messina, Italy</p></div>
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">*Correspondence: Teodora Chamova <span>teodoratch@abv.bg</span></p>
</div>
<div class="fn" id="fn001"><p>This article was submitted to Neurogenetics, a section of the journal Frontiers in Neurology</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Dec 28; Accepted 2022 Feb 28; Collection date 2022.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2022 Chamova, Gospodinova, Asenov, Todorov, Pavlova, Kirov, Cherninkova, Kastreva, Taneva, Blagoeva, Zhelyazkova, Antimov, Chobanov, Todorova and Tournev.</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9024406  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35463150/" class="usa-link">35463150</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is a rare, autosomal-dominant (AD) multisystem disorder resulting from the extracellular deposition of amyloid fibrils formed by a destabilized mutant form of transthyretin (TTR), a transport protein predominantly produced by the liver.</p>
<section id="sec1"><h3 class="pmc_sec_title">Aim</h3>
<p>The aims of the current study are to demonstrate the Bulgarian experience with the screening programs among the high-risk patient population over the last 7 years, to present the results from the therapy with TTR stabilizer in our cohort, as well as to stress on the importance of a follow-up of asymptomatic carriers with TTR pathogenic variants by a multidisciplinary team of specialists.</p></section><section id="sec2"><h3 class="pmc_sec_title">Materials and Methods</h3>
<p>In 2014, a screening program among the high-risk patient population for ATTRv was initiated in Bulgaria. On one hand, it was conducted to identify new patients and families among people with “red flag” clinical features, while on the other hand, the program aimed to identify TTR mutation carriers among the families with already genetically proven diagnoses. Sanger sequencing methodology was used to make fast target testing for mutations in the <em>TTR</em> gene in the suspected individuals. All of the identified carriers underwent subsequent evaluation for neurological, cardiac, gastroenterological, and neuro-ophthalmological involvement. Those considered affected were provided with multidisciplinary treatment and a follow-up.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>As a result of a 7-year selective screening program among the high-risk patient population and relatives of genetically verified affected individuals, 340 carriers of TTR mutations were identified in Bulgaria with the following gene defects: 78.53% with Glu89Gln, 10.29% with Val30Met, 8.24% with Ser77Phe, 2.06% with Gly47Glu, and 0.59% with Ser52Pro. All of these affected displayed a mixed phenotype with variable ages at onset and rate of progression, according to their mutation. From the 150 patients treated with TTR stabilizer, 84 remained stable, while in other 66 patients the treatment was terminated either because of polyneuropathy progression or due to death. A program for a regular follow-up of asymptomatic carriers in the last 3 years enabled us to detect the transition of 39/65 to symptomatic patients and to initiate treatment in a timely manner.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p>Bulgarian ATTRv patients display a mixed phenotype with some clinical peculiarities for each mutation that should be considered when treating the affected and the follow-up of the asymptomatic carriers of a specific gene defect.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> ATTRv, screening, asymptomatic carrier, follow up, phenotype</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is a rare and debilitating multisystem disorder resulting from the extracellular deposition of amyloid fibrils formed by a destabilized mutant form of transthyretin (TTR), a transport protein predominantly produced by the liver (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>, <a href="#B2" class="usa-link" aria-describedby="B2">2</a>). It has an autosomal-dominant (AD) trait of inheritance and is associated with more than 140 different mutations in the <em>TTR</em> gene (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>–<a href="#B5" class="usa-link" aria-describedby="B5">5</a>). The age at onset is highly variable from the second to the ninth decade of life (<a href="#B6" class="usa-link" aria-describedby="B6">6</a>), and the clinical phenotype varies from a progressive sensorimotor and autonomic neuropathy to an infiltrative cardiomyopathy (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>, <a href="#B6" class="usa-link" aria-describedby="B6">6</a>).</p>
<p>Current disease-modifying therapies for ATTRv that aim to stabilize the TTR tetramer (Diflunisal and Tafamidis) or to reduce mutant TTR production (liver transplantation or gene-silencing therapies) (<a href="#B7" class="usa-link" aria-describedby="B7">7</a>) are associated with improved outcomes when initiated early in the disease course, therefore timely diagnosis is crucial.</p>
<p>Bulgaria is among the countries with a high number of ATTRv amyloidosis cases. The most common TTR pathogenic variant for the Bulgarian patients is Glu89Gln (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.3</a>: c.325G&gt;C, p.Glu109Gln, rs121918082) (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>–<a href="#B10" class="usa-link" aria-describedby="B10">10</a>), but four other less prevalent mutations have been found as well—Val30Met (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.3</a>: c.148G&gt;A, p.Val50Met, rs28933979), Ser77Phe (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.3</a>:c.290C&gt;T, p.Ser97Phe), Gly47Glu (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.3</a>:c.200G&gt;A, p.Gly67Glu, rs121918090), and Ser52Pro (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.3</a>: c.214T&gt;C, p.Ser72Pro). The founder effect has been proven for some of the TTR mutations in Bulgaria (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>, <a href="#B11" class="usa-link" aria-describedby="B11">11</a>).</p>
<p>The expert ATTR Amyloidosis Centre at the University Hospital “Alexandrovska” in Sofia, Bulgaria, was set up in early 2016 and it is currently a member of the European Reference Network for Neuromuscular Disease (ERN-EURO NMD) (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>). The Bulgarian multidisciplinary team in this center of excellence (CoE) encompasses different specialists, dealing with the diverse aspects of this disorder: neurologists, ophthalmologists, cardiologists, gastroenterologists, nephrologists, geneticists, physiotherapists, psychologists, pathologists, and nurses. The CoE has been performing a screening program for diagnosing ATTRv in the high-risk patient population over the last 7 years (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>) and a program for a follow-up of asymptomatic carriers of mutations in the <em>TTR</em> gene since 2018.</p>
<p>The aims of the current study are to demonstrate the Bulgarian experience with the screening programs among the high-risk patient population over the last 7 years, to present the results from the therapy with TTR stabilizer in the Bulgarian cohort, as well as to stress on the importance of a follow-up of asymptomatic carriers with <em>TTR</em> pathogenic variants by a multidisciplinary team of specialists.</p></section><section id="s2"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="sec7"><h3 class="pmc_sec_title">Selective Screening Program</h3>
<p>Early diagnosis is critical for the effectiveness of the treatment and the quality of life of patients. In this respect, in 2014 a screening program among the high-risk patient population for ATTRv was initiated in Bulgaria. On one hand, it was conducted to identify new patients and families among people with the following clinical features: bilateral carpal tunnel syndrome and/or axonal polyneuropathy of unknown cause and/or restrictive cardiomyopathy with infiltrative features and/or diarrhea/constipation/weight loss. The family history, consistent with AD trait of inheritance and origin from the already identified endemic regions were added as inclusion criteria as well. On the other hand, the program aimed to identify <em>TTR</em> mutation carriers among the families with already genetically proven diagnoses.</p>
<p>A public awareness campaign was organized. Our CoE team made the medical specialists familiar with the aims and stages of the selective screening program by organizing regional and national meetings with the participation of general practitioners (GPs), different specialists (neurologists, cardiologists, and gastroenterologists). Nine common meetings with the ATTRv patient organization were performed during this 7-year period. All participants in the screening were informed in writing about their carrier status, and further consultations were provided individually. Genetic counseling was offered to all of the detected carriers.</p>
<p>The members of the team were performing field studies and were visiting the affected families in their towns and villages. This “door to door” information campaign had the following main standpoints: what the disease itself is, how it could appear, how it could be inherited and transmitted to the offspring, what the genetic analysis itself is, what could the detected carriers expect, how often must the carriers be followed according to the age, and when the treatment should be initiated. A patient manual, describing all of the above issues was elaborated and provided to those affected and their families.</p>
<p>The genetic diagnostic approach in Bulgaria started with the evaluation of the frequency and the geographic distribution of the most common <em>TTR</em> mutations. We used the Sanger sequencing methodology, which allowed us to make fast target testing of the suspected individuals. Based on this, the genetic screening started with sequencing of exon 3 of the <em>TTR</em> gene as the most frequent mutations Glu89Gln and Ser77Phe are located there. If exon 3 was negative for pathogenic variants, exon 2 was sequenced for Val30Met and Gly47Glu. In case of negative target screening, we proceeded with a full study of the coding sequence of the <em>TTR</em> gene. As long as all the known amyloidogenic mutations are located in the <em>TTR</em> coding sequence, this test was enough to confirm or exclude the hereditary form of ATTR.</p>
<p>All of the genetically verified patients underwent clinical assessment at the time of the diagnosis and a routine follow-up every 6 months, including neurological examination, The neuropathy impairment score (NIS) (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>), evaluation of familial amyloid polyneuropathy (FAP) stage, and polyneuropathy disability score (PND) (<a href="#B14" class="usa-link" aria-describedby="B14">14</a>). Neurophysiological assessments encompassed electromyography with nerve conduction studies (NCSs), sympathetic skin response (SSR), and electrochemical skin conductance (ESC), measured by Sudoscan (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>). Motor (tibial, peroneal, median, and ulnar) and sensory (sural, superficial peroneal, median, and ulnar) nerve conductions (NCVs) were assessed on both sides of the body. The SSR was recorded with electrodes on the hand (and foot) dorsum and on the corresponding sites of palm and sole. Peak-to-peak amplitude was assessed (<a href="#B16" class="usa-link" aria-describedby="B16">16</a>).</p>
<p>Cardiac involvement was evaluated in all of the affected patients by 12-lead electrocardiography (ECG) and transthoracic echocardiography. In patients positive for ATTRv, cardiac involvement was defined echocardiographically as an end-diastolic left ventricular (LV) wall thickness more than 12 mm in the absence of any other causes for ventricular hypertrophy according to a consensus (<a href="#B17" class="usa-link" aria-describedby="B17">17</a>). The presence of infiltrative features, such as interatrial septal and valve thickening, as well as the presence of apical sparing, characteristic ECG findings supported the diagnosis. 99mTc-PYP bone scintigraphy and, in some of the patients, cardiac magnetic resonance (CMR) were performed when the findings from the echocardiography exam were equivocal. An ECG was considered abnormal when it revealed one or more of the following signs: different from sinus rhythm and conduction disturbances (right bundle branch block, left bundle branch block, A–V block, left anterior fascicular block, left posterior fascicular block, and unspecific intraventricular delay), low voltage of the QRS complex, deviations in the ST segment and <em>T</em> wave, pathological <em>Q</em> wave, or a prolongation of the QT interval. Low-voltage amplitude in the limb leads was defined by a mean QRS amplitude in leads I, II, III, aVL, and aVF of 0.5 mV or &lt;1 mV in all precordial leads (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>). Complete echocardiographic examinations, including 2D, M-mode, spectral and color Doppler techniques, tissue Doppler imaging (TDI), and 2D speckle tracking echocardiography (STE), were done in all patients. The echocardiographic studies were performed and recorded, and all the measurements were done in accordance with internationally approved standards (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>–<a href="#B20" class="usa-link" aria-describedby="B20">20</a>).</p>
<p>Gastrointestinal involvement was assessed in all by taking patients' history, biomarkers for intestinal inflammation (fecal calprotectin), hydrogen breath test, abdominal ultrasound, and endoscopies with staging biopsies for Congo red staining (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>, <a href="#B21" class="usa-link" aria-describedby="B21">21</a>).</p>
<p>In total, 69 patients with ATTRv (40 men and 29 women) were ophthalmologically examined in the Clinic of Nervous diseases, Neuro-ophthalmology office, Sofia, by one senior ophthalmologist. The ophthalmological examination consists of the test for visual acuity, slit-lamp examination of the anterior eye segment, pupil function, slit lamp examination of the ocular fundus using +90D lens, an examination of lacrimal function using Schirmer's test and tear break-up time (TBUT), and intraocular pressure and ocular motility was performed.</p></section><section id="sec8"><h3 class="pmc_sec_title">Asymptomatic Carriers</h3>
<p>During our COE's genetic screening program, the asymptomatic adult family members of already verified ATTRv cases had an opportunity for further evaluations, which allowed us to perform structured monitoring of individuals who carry a mutant <em>TTR</em> gene and enhanced the possibility of early diagnosis of the disease (<a href="#B22" class="usa-link" aria-describedby="B22">22</a>). Genetic counseling allowed the family members to make an informed decision about genetic testing for <em>TTR</em>.</p>
<p>All these asymptomatic carriers were invited for neurological evaluation, NCS, SSR, Sudoscan, and cardiac evaluation with ECG, echocardiography, and in case of suspicion for cardiac involvement-−99mTc-PYP bone scintigraphy with a frequency, according to their age and mutation. The transition from asymptomatic to the symptomatic patient was based on the already approved European guidelines (<a href="#B22" class="usa-link" aria-describedby="B22">22</a>).</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="sec10"><h3 class="pmc_sec_title">Screening Program</h3>
<p>The first ATTRv family was diagnosed in Bulgaria in 2008.</p>
<p>In the 7 years of the screening program (from 2014 to 2021), 954 people fulfilling the above-mentioned inclusion criteria were tested and 340 carriers (179 male and 161 female) of TTR mutations both affected and asymptomatic belonging to 127 pedigrees were identified <a href="#F1" class="usa-link">Figure 1</a>. They are distributed according to the TTR mutation as follows: 267 (78.53%; 140 male and 127 female) with Glu89Gln; 35 (10.29%; 22 male and 13 female) with Val30Met; 28 (8.24%; 13 male and 15 female) with Ser77Phe; 7 (2.06%; 4 male and 3 female) with Gly47Glu; 2 (0.59%; 2 female) with Ser52Pro, and 1 with a compound heterozygous carrier of Val30Met and Glu89Gln. In total, 470 of the tested individuals belonging to these 127 pedigrees did not carry any mutation in the TTR gene.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9024406_fneur-13-844595-g0001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f9a/9024406/251d5efdc34a/fneur-13-844595-g0001.jpg" loading="lazy" height="362" width="708" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution in percentage of the Bulgarian hereditary transthyretin amyloidosis (ATTRv) patients, according to their mutation: 78.53% with Glu89Gln, 10.29% with Val30Met, 8.24% with Ser77Phe, 2.06% with Gly47Glu, and 0.59% with Ser52Pro.</p></figcaption></figure><p>The calculated average carrier frequency of the <em>TTR</em> mutations in the screened Bulgarian families corresponds with the AD pattern of inheritance with a theoretical risk of transmission of 50%. Despite the particular mutations, the frequency of the TTR mutation carriers from all screened individuals originating from ATTRv-affected families is 42% (<a href="#SM1" class="usa-link">Supplementary Table 1</a>).</p>
<p>Of the remaining 144 patients, who neither belonged to an ATTRv family, nor were carrying a <em>TTR</em> mutation 134 had a late-onset axonal polyneuropathy, while the other 10 displayed restrictive cardiomyopathy with infiltrative features.</p>
<p>Epidemiological data of the affected patients are presented in <a href="#T1" class="usa-link">Table 1</a>, while the predominant clinical features according to patients' mutation are presented in <a href="#T2" class="usa-link">Table 2</a>.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Epidemiological data of Bulgarian hereditary transthyretin amyloidosis (ATTRv) patients.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Mutation in <em>TTR</em> gene</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>Number of patients</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>Mean age at onset (years)</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>Range of age at onset (years)</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>Median survival (years)</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>Mean time from symptoms onset to diagnosis (years)</strong>
</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Glu89Gln</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Total</td>
<td valign="top" align="center" rowspan="1" colspan="1">184</td>
<td valign="top" align="center" rowspan="1" colspan="1">51.21</td>
<td valign="top" align="center" rowspan="1" colspan="1">39–69</td>
<td valign="top" align="center" rowspan="1" colspan="1">11.55 ± 0.83</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.67 ± 3.26</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Male</td>
<td valign="top" align="center" rowspan="1" colspan="1">90</td>
<td valign="top" align="center" rowspan="1" colspan="1">48.33</td>
<td valign="top" align="center" rowspan="1" colspan="1">39–58</td>
<td valign="top" align="center" rowspan="1" colspan="1">10.65</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.04 ± 2.03</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Female</td>
<td valign="top" align="center" rowspan="1" colspan="1">94</td>
<td valign="top" align="center" rowspan="1" colspan="1">54.09</td>
<td valign="top" align="center" rowspan="1" colspan="1">43–69</td>
<td valign="top" align="center" rowspan="1" colspan="1">11.87</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.34 ± 4.10</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Val30Met</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Total</td>
<td valign="top" align="center" rowspan="1" colspan="1">27</td>
<td valign="top" align="center" rowspan="1" colspan="1">66.66</td>
<td valign="top" align="center" rowspan="1" colspan="1">54–74</td>
<td valign="top" align="center" rowspan="1" colspan="1">8.98</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.65 ± 2.84</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Male</td>
<td valign="top" align="center" rowspan="1" colspan="1">18</td>
<td valign="top" align="center" rowspan="1" colspan="1">64.94</td>
<td valign="top" align="center" rowspan="1" colspan="1">54–73</td>
<td valign="top" align="center" rowspan="1" colspan="1">8.98</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.03 ± 2.90</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Female</td>
<td valign="top" align="center" rowspan="1" colspan="1">9</td>
<td valign="top" align="center" rowspan="1" colspan="1">68.38</td>
<td valign="top" align="center" rowspan="1" colspan="1">62–74</td>
<td valign="top" align="center" rowspan="1" colspan="1">No deceased females</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.1 ± 1.9</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Ser77Phe</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Total</td>
<td valign="top" align="center" rowspan="1" colspan="1">12</td>
<td valign="top" align="center" rowspan="1" colspan="1">58.34</td>
<td valign="top" align="center" rowspan="1" colspan="1">50–64</td>
<td valign="top" align="center" rowspan="1" colspan="1">8.30 ± 0.82</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.75 ± 1.71</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Male</td>
<td valign="top" align="center" rowspan="1" colspan="1">6</td>
<td valign="top" align="center" rowspan="1" colspan="1">56.76</td>
<td valign="top" align="center" rowspan="1" colspan="1">50–62</td>
<td valign="top" align="center" rowspan="1" colspan="1">7.30 ± 0.82</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.8 ± 1.93</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Female</td>
<td valign="top" align="center" rowspan="1" colspan="1">6</td>
<td valign="top" align="center" rowspan="1" colspan="1">59.92</td>
<td valign="top" align="center" rowspan="1" colspan="1">53–64</td>
<td valign="top" align="center" rowspan="1" colspan="1">9.00</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.67 ± 1.24</td>
</tr>
<tr>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Only one deceased female</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Gly47Glu</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">6</td>
<td valign="top" align="center" rowspan="1" colspan="1">29.15</td>
<td valign="top" align="center" rowspan="1" colspan="1">18–38</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.68 ± 0.41</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.67 ± 1.70</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Male</td>
<td valign="top" align="center" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">28.5</td>
<td valign="top" align="center" rowspan="1" colspan="1">18–32</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.58</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.55 ± 1.12</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Female</td>
<td valign="top" align="center" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">29.8</td>
<td valign="top" align="center" rowspan="1" colspan="1">18–38</td>
<td valign="top" align="center" rowspan="1" colspan="1">No deceased females</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.01 ± 1.18</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Semiquantitative overview of clinical presentation frequency.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Mutation in <em>TTR</em> gene</strong>
</th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;" rowspan="1">
<strong>Neurological presentation</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>AD</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>CI</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>GI</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>Weight loss</strong>
</th>
</tr>
<tr>
<th rowspan="1" colspan="1"></th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>PNP</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>SFN</strong>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<strong>CTS</strong>
</th>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Glu89Gln</td>
<td valign="top" align="center" rowspan="1" colspan="1">+++</td>
<td valign="top" align="center" rowspan="1" colspan="1">+++</td>
<td valign="top" align="center" rowspan="1" colspan="1">+++</td>
<td valign="top" align="center" rowspan="1" colspan="1">+</td>
<td valign="top" align="center" rowspan="1" colspan="1">+++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Val30Met</td>
<td valign="top" align="center" rowspan="1" colspan="1">+++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">+</td>
<td valign="top" align="center" rowspan="1" colspan="1">+</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Ser77Phe</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">+</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Gly47Glu</td>
<td valign="top" align="center" rowspan="1" colspan="1">+</td>
<td valign="top" align="center" rowspan="1" colspan="1">+++</td>
<td valign="top" align="center" rowspan="1" colspan="1">+</td>
<td valign="top" align="center" rowspan="1" colspan="1">+++</td>
<td valign="top" align="center" rowspan="1" colspan="1">++</td>
<td valign="top" align="center" rowspan="1" colspan="1">+++</td>
<td valign="top" align="center" rowspan="1" colspan="1">+++</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p32">
<p><em>(+ is uncommon or mild, + + is average or moderate; + + + is frequent or intense)</em>.</p>
<p><em>SFN, small fiber neuropathy; CTS, carpal tunnel syndrome; AD, autonomic dysfunction; CI, cardiac involvement; GI, gastrointestinal involvement</em>.</p>
</div></div></section><p><em>Glu89Gln</em> was found to be the most frequent <em>TTR</em> mutation in Bulgaria (78.53%), with an endemic region, consisting of two districts: Blagoevgrad and Kjustendil, in the south-western part of the country. The focus is 200 km long and is located along the border with the Republic of Northern Macedonia. Due to internal migrations, patients with this mutation were found in the north-eastern part of Bulgaria as well. They were less frequently identified in central Bulgaria. The region is referred as endemic based on the data from National Statistical Institute because the incidence is estimated to be 1/7,636, while the prevalence is 1/4,150 (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>).</p>
<p>There is a statistically significant difference in the mean age at onset between male symptomatic carriers with Glu89Gln (48.33 years varying between 39 and 58 years) and female patients (54.09 years, varying between 43 and 69 years). The median survival was 11.55 ± 0.83 years, ranging between 3 and 20 years (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>). The clinical phenotype encompassed: bilateral carpal tunnel syndrome; sensory, motor, and autonomic neuropathy with painful dysesthesias more pronounced in the feet; the loss of vibration and temperature sensations; sensory ataxia, autonomic dysfunction; distal muscle weakness; restrictive cardiomyopathy with heart failure signs and symptoms, rhythm and conduction disturbances, and syncope; and constipation/diarrhea, weight loss, and subsequent cachexia.</p>
<p>Polyneuropathy was considered as the predominant initial symptom. Rarely, peripheral nerve, cardiac, and gastrointestinal symptoms were observed simultaneously in the beginning of the disease, thus broadening the differential diagnosis. In only 30 of the patients, cardiac symptoms were reported prior to other symptoms for years. Patients with Glu89Gln developed earlier and more severe restrictive cardiomyopathy compared to patients with Val30Met. Gastrointestinal involvement was found as an initial sign-in for only 7 of the affected patients.</p>
<p>Decreased tear secretion (&lt;10 mm moisture of the paper strip for 5 min) was found in 14/23 patients (28 eyes, 60.9%). Abnormal TBUT test (an initial break-up of the tear film &lt;6 s) was found in 8/14 patients (16 eyes, 44.4%). In the slit lamp examination, suspected bilateral amyloid deposition on the anterior capsule of the lens was found in only one patient with ATTRv—a 68-year-old female (2 eyes, 1.4%) with Glu89Gln mutation of the <em>TTR</em> gene. Vitreous amyloidosis was found in two examined ones. The vitreous opacities were with the characteristic of fibrils, rounded and veil-like condensates, or by the type of pseudopodia lentis. No severe functional opacity-related visual deficits were observed in any of the affected patients and did not require vitrectomy to confirm the amyloid immunohistologically. In two female patients with ATTRv, about 7 years after disease onset, bilateral ptosis, and mild unilateral abducens nerve lesion were observed. Brain magnetic resonance imaging (MRI) was normal in both.</p>
<p>The clinical phenotype of our <em>Glu89Gln</em> group was mixed, with the involvement of the peripheral nerves, heart, and gastrointestinal system.</p>
<p>In total, 14 affected families with <em>Val30Met</em> were identified in Bulgaria. In general, the distribution of patients with this mutation across the country is more widespread. However, there is also a small endemic region in the Smolyan district.</p>
<p>The incidence of the mutation in the endemic region is 1/9,000 and its prevalence is 1/3,200 (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>). Reports of positive family history were present in &lt;25–30% of the affected patients, thus often the disease was interpreted as “sporadic.”</p>
<p>The clinical phenotype was of a late-onset disease with a mean age at the onset of 65.57 years (age range: 55.4–76 years). The median survival was 8.98 years (range: 6–9 years). All of the patients had axonal sensory-motor and autonomic polyneuropathy associated with LV hypertrophy and left atrial enlargement. Most of them had alternating constipation-diarrhea, impotence, orthostatic hypotension, and urinary incontinence as a later clinical feature. Vitreous amyloidosis was found in only one patient.</p>
<p>At diagnosis clinical phenotype was mixed—peripheral nerve and cardiac involvement with nerves predominantly affected. Clinically, the phenotype was “milder,” compared to the other mutations described in Bulgaria.</p>
<p>In total, 12 affected families with <em>Ser77Phe</em> were identified in Bulgaria, all of them originating from the village of Vakarel, located 25 km from the capital of Bulgaria, Sofia. Positive family history was reported in 85% of the cases. The incidence of the mutation in the endemic region is 1/1,600 and its prevalence is 1/850 (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>).</p>
<p>Clinical phenotype is of a late-onset form with a mean age at onset 57.60 years. (52.3–61.8 years). Median survival was 7.30 ± 0.82 years (ranging from 4 to 9 years). All the patients had axonal sensory-motor and autonomic polyneuropathy associated with restrictive cardiomyopathy. The majority of them had alternating constipation-diarrhea, impotence, orthostatic hypotension, and urinary incontinence as late clinical features. In only one affected vitreous amyloidosis was observed.</p>
<p>The clinical phenotype at diagnosis was mixed, most often neuropathic and cardiac, while gastrointestinal involvement was observed in the advanced stages. The phenotype was considered as similar to Glu89Gln.</p>
<p>Two large Roma families, carrying the mutation <em>Gly47Glu</em> in three generations were identified in the Russe district in the north-eastern part of the country. The average age at onset of the disease was 28.5 years (18–38 years) in the last generation. There were data for four men who have died between the ages of 30 and 35 years. In the first and the second generations, the disease has started later (average age at the onset−40 years) and three patients have died at 46 years of age. Mean survival was estimated as 4.68 ± 0.41 years, ranging from 4 to 6 years. Genetic anticipation in the age at onset of the disease was observed. The presenting symptoms were pain in the feet, nausea, vomiting, weight loss up to 50 kg, and diarrhea. The clinical course was rapidly progressive.</p>
<p>The clinical phenotype encompassed early and severe gastrointestinal manifestations (severe vomiting and alternating constipation-diarrhea), weight loss, distal and prominent weakness and hypotrophy of all limbs, tendon arreflexia in the lower limbs, decreased vibration sensation in lower limbs, early impotence, severe orthostatic hypotension, restrictive cardiomyopathy, heart failure, and microalbuminuria. The clinical phenotype at diagnosis was mixed, with gastrointestinal, cardiac involvement, and polyneuropathy. Kidney involvement was found as well in three affected.</p>
<p>One affected patient with <em>Ser52Pro</em> from Veliko Tarnovo region was identified. The patient had a mother with the same disease, who had died at 63 years. His age at onset was 44.2 years. He died at 53 years. The clinical phenotype at diagnosis was mixed, most often neuropathic and cardiac with GI involvement in more advanced stages. It included axonal sensory-motor and autonomic polyneuropathy, diarrhea, weight loss, severe orthostatic hypotension, restrictive cardiomyopathy, heart failure, albuminuria, renal insufficiency, and secondary anemia.</p>
<p>In the country with a population of 7.3 million, the average incidence of new cases for all mutations and clinically diagnosed patients for a 7-year follow-up is estimated to be 1/42,000. The prevalence of the disease averages 1/26,000.</p>
<p>The most common misdiagnosis in our group with initial neurological involvement were bilateral carpal tunnel syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), diabetic polyneuropathy, toxic polyneuropathy, cervical, and lumbosacral radiculopathy. In total, 48 affected had a medical history of prior diagnostic errors. They were distributed as follows: idiopathic carpal tunnel syndrome (18%); cervical radiculopathy (12%), lumbosacral radiculopathy (16%), chronic inflammatory demyelinating polyradiculoneuropathy (14%), idiopathic axonal polyneuropathy (10%), toxic (alcoholic) polyneuropathy (10%), diabetic polyneuropathy (4%), vitamin B12-deficient polyneuropathy (4%), drug-induced polyneuropathy (2%), and polyneuropathy associated with gluten sensitivity (2%).</p>
<p>The patients with predominant cardiac phenotype had received the following misdiagnosis—hypertensive heart disease when there was mild to moderate LV hypertrophy or hypertrophic cardiomyopathy with more severe hypertrophy. In total, 11 patients (22.9%) with predominant cardiac phenotype and severe LV hypertrophy (&gt;15 mm) had been misdiagnosed with hypertrophic cardiomyopathy, in 2 of them intraventricular gradient was found, 1 patient had been tested also for Fabry disease. One patient with severe LV hypertrophy had undergone aortic valve replacement and the extra-cardiac symptoms were the clues for ATTR amyloidosis. Mild to moderate hypertrophy had been associated with concomitant arterial hypertension.</p>
<p>In patients with initial gastrointestinal symptoms, the misdiagnoses were distributed as follows: chronic colitis (29%), irritable bowel syndrome (11%), chronic atrophic gastritis (4%), reflux esophagitis (4%), polyp of the sigmoid colon (4%), rectal carcinoma (4%), and pyloric stenosis (2%).</p>
<p>In the first 2 years, around 67% of the diagnosed were in FAP stage 2 or 3 with a diagnostic delay 5–6 years, which was related to poor outcome. Currently, the increased awareness among medical specialists and the identification of different endemic regions for each mutation across the country decreased the diagnostic delay to &lt;2 years after the initial symptoms.</p></section><section id="sec11"><h3 class="pmc_sec_title">Follow-Up of Asymptomatic Carriers</h3>
<p>For the last 3 years, 65 carriers of TTR mutations were followed up in accordance with the approved recommendations for age and frequency (<a href="#B22" class="usa-link" aria-describedby="B22">22</a>). According to their mutations, they were subdivided into the following groups: 56 carriers of Glu89Gln, 3 carriers of Val30Met, 4 carriers of Ser77Phe, and 2 carriers of Gly47Glu.</p>
<p>During this period, 39 of them transitioned to symptomatic with FAP stage I and the PND score 1. In 38 people, abnormalities from the neurological examination, consistent with either bilateral carpal tunnel syndrome or sensory-motor polyneuropathy with attenuated Achillis tendon reflexes and distal hypesthesia in the lower limbs were reported. In 33 of these carriers, the NCS were abnormal with sensory nerve action potential- abbreviation (SNAP) of the sural and the superficial peroneal nerves being decreased or absent in 30 and distal latencies of the median nerve being prolonged for the SNAP and/or compound motor action potential (CMAP). Sudoscan revealed a mild-to-moderate decrease of the electrochemical conductance in 31/38, while SSR was abnormal in all of them. Cardiac impairment was observed in 19/39.</p>
<p>For the period 2014–2021 in 150 patients at FAP stage I, the treatment with Tafamidis 20 mg was initiated. During this period, 84 affected patients remained stable in terms of neurological and cardiologic involvement and continued their treatment with the TTR stabilizer.</p>
<p>The treatment with Tafamidis was terminated in other 66 patients either because of polyneuropathy progression or due to death. Those affected were distributed as follows: 2 patients with Ser77Phe (1.3% from all the treated patients), 3 with Val30Met (2%), 2 with Gly47Glu (1.3%), and 59 with Glu89Gln (39.3%). In the 34 affected patients, the progression of the sensory-motor and autonomic polyneuropathy and transition to FAP stage II were observed and were subsequently switched to gene-silencing therapies. Although all the patients were in FAP stage I at the time of treatment initiation, the heart involvement varied broadly. Clinical manifestations were consistent in 11 patients with NYHA class I, in 20 with NYHA class II, and in 30 patients with NYHA class III. In total, 37 patients demonstrated stage III LV diastolic dysfunction on echocardiography and 32 affected have died: 2 with Ser77Phe mutation and 2 with Val30Met have died suddenly, 1 patient with Gly47Glu has died from gastrointestinal bleeding and the remaining 27 patients were with Glu89Gln mutation-−15 patients have died with advanced heart failure, 7 of them died suddenly, 3 from stroke, 4 from disease progression—bedridden with cachexia and severe autonomic dysfunction, 5 patients from extra-cardiac causes: 1 from esophageal cancer, 1 from acute renal failure, 1 from urosepsis, and two from COVID-19 infection.</p>
<p>Rehabilitation as a key element of the multidisciplinary treatment process of ATTRv was provided to all of the affected patients. It was followed up and updated every 6 months, according to the needs of the affected patients in our CoE.</p></section><section id="sec12"><h3 class="pmc_sec_title">Psychological Support</h3>
<p>As the diagnosis of ATTRv is often delayed, all patients often share their frustration in seeing many doctors without exact diagnosis and treatment. Psychological support is needed and directed to the patients, carriers, and their families. The patients must have available psychological space in which they can share their feelings and thoughts related with the diagnostic of the disease and managing of the disease. These patients bear a significant emotional burden, a sense of doom, the fear of death, and often a sense of guilt. In most of the cases, these experiences are not shared with their relatives, which further aggravate the situation of patients and lead to internal self-isolation. The psychological support provides a safe and relaxed environment in which patients can talk freely about their condition. Furthermore, it helps the acceptance of the disease and improves their self-perception and the aim of relieving the feeling of being sick.</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>Hereditary transthyretin amyloidosis is the most serious hereditary polyneuropathy of adult-onset and a progressive, devastating, and life-threatening disease. Timely and appropriate diagnosis can be relatively difficult because the initial presenting symptoms may be vague and attributed to other more common conditions (<a href="#B2" class="usa-link" aria-describedby="B2">2</a>, <a href="#B6" class="usa-link" aria-describedby="B6">6</a>, <a href="#B24" class="usa-link" aria-describedby="B24">24</a>). The affected with polyneuropathy have been misdiagnosed with CIDP (<a href="#B25" class="usa-link" aria-describedby="B25">25</a>), diabetic polyneuropathy, toxic polyneuropathy, etc. Patients with predominant cardiac phenotype had received several misdiagnoses—hypertensive heart disease when there was mild to moderate LV hypertrophy or hypertrophic cardiomyopathy with more severe hypertrophy (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>). Delays in the diagnosis of ATTR can have serious consequences for patients who may develop severe end-organ impairment. In this respect, selective screening programs among the high-risk patient population have proven to be a valuable tool for early diagnosis and timely treatment in the field of rare disorders (<a href="#B2" class="usa-link" aria-describedby="B2">2</a>).</p>
<p>For the last 7 years, out of the 954 tested, the Bulgarian genetic selective screening program for ATTRv resulted in the identification of 340 carriers of TTR mutations. In the first 2 years, many of the diagnosed were in FAP stage 2 or 3, which was related to a poor outcome. However, subsequently, increased awareness among medical specialists and the identification of different endemic regions for each mutation across the country decreased the delay in diagnosis.</p>
<p>The data obtained from this research indicated that there were endemic regions in the country of with different areas for individual mutations—Glu89Gln, Ser77Phe, and Val30Met. The incidence and prevalence of the three mutations regarding the place of origin of patients fulfilled the criteria for the endemic areas—between 1/1,000 and 1/10,000 (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>).</p>
<p>Currently, there is no Bulgarian genomic database. Available genetic data for the Bulgarian population could be found either in the literature data or in some of the international databases. For example, the GnomAD v.2.1.1 (<a href="#B26" class="usa-link" aria-describedby="B26">26</a>) database contains data for Bulgarian exomes and genomes. The Val30Met mutation is found there with a frequency of 0.0003745. However, the publicly available genetic data for the Bulgarian population is far from sufficient, so our medical and scientific community hopes that a database with more complete genetic data will be built in the near future. Glu89Gln as the most frequent TTR mutation in Bulgaria (78.53%) was proven to be a specific regional Balkan-Mediterranean mutation, identified in the Republic of North Macedonia, Turkey, Bulgaria, Kosovo, and Italy (Sicily) (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>, <a href="#B11" class="usa-link" aria-describedby="B11">11</a>, <a href="#B23" class="usa-link" aria-describedby="B23">23</a>, <a href="#B27" class="usa-link" aria-describedby="B27">27</a>). The age at onset did not differ significantly between the above-mentioned countries (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>, <a href="#B27" class="usa-link" aria-describedby="B27">27</a>). In a comparison study from the Transthyretin Amyloidosis Outcomes Survey (THAOS) registry of patients with ATTRv Glu89Gln amyloidosis, originating from Bulgaria and Italy, there were notable phenotypic differences in terms of organ involvement, with the cardiac phenotype more common in Bulgaria and the neurologic phenotype more common in Italy. Such differences could be explained by diverse factors: the symptom duration, first diagnosing physician, and other genetic and epigenetic factors (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>). More than 30% of the patients with Glu89Gln had a mixed phenotype, suggesting a potential role of multiple genetic and/or environmental factors as well (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>).</p>
<p>Although Val30Met is the most frequent <em>TTR</em> mutation and distributed worldwide, in Bulgaria it is the second most common. All the affected patients had a late-onset and mixed phenotype, similar to previous reports (<a href="#B29" class="usa-link" aria-describedby="B29">29</a>, <a href="#B30" class="usa-link" aria-describedby="B30">30</a>).</p>
<p>Ser77Phe has the highest incidence in the French population (the south-western—Toulouse area). Historically, it can be speculated that this mutation has been transmitted during the Middle Ages by French crusaders, but still this has to be proven by a haplotype analysis. There is another hypothesis that it was transferred to France by the Bogomils after their expulsion from Bulgaria in the Middle Ages (<a href="#B31" class="usa-link" aria-describedby="B31">31</a>).</p>
<p>Gly47Glu was the most severe mutation in terms of age at the onset and rate of progression among the Bulgarian groups. In this respect, it is debatable what treatment to initiate even in the initial stages with very mild features (<a href="#B32" class="usa-link" aria-describedby="B32">32</a>, <a href="#B33" class="usa-link" aria-describedby="B33">33</a>).</p>
<p>The majority (95%) of our patients showed a mixed phenotype (cardiac and neurological) at the time of diagnosis, regardless of their mutation.</p>
<p>Small unmyelinated fibers were affected earlier than the myelinated ones, which was proven by abnormal SSR and Sudoscan testing in all the symptomatic cases (<a href="#B24" class="usa-link" aria-describedby="B24">24</a>). SSR in our cohort seemed more sensitive than Sudoscan in the detection of the transition from an asymptomatic to a symptomatic state. Interestingly, we observed an advanced heart involvement even in patients with mild polyneuropathy at the time of diagnosis and <em>vice versa</em>, thus proving the presence of high heterogeneity in the same pedigree.</p>
<p>Our findings demonstrated that patients with Glu89Gln mutation may have a prolonged period of asymptomatic amyloid infiltration in the heart and the symptoms are further concealed by the development of the neuropathy. Thus, an earlier identification of the cardiomyopathy is needed through a close follow-up of patients and the mutation carriers. Many of the <em>TTR</em> pathogenic variants have heterogeneous phenotypic manifestation among different populations or even among the same family (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>, <a href="#B34" class="usa-link" aria-describedby="B34">34</a>, <a href="#B35" class="usa-link" aria-describedby="B35">35</a>). The differences in organ and tissue involvement in the context of the same <em>TTR</em> variant imply the influence of other genetic and epigenetic factors upon the clinical manifestation. There are various studies proposing the effect of non-coding cis- and trans-acting regulatory genetic factors on the TTR expression and tissue-specific amyloid formation, as well as the age at disease onset (<a href="#B35" class="usa-link" aria-describedby="B35">35</a>–<a href="#B39" class="usa-link" aria-describedby="B39">39</a>).</p>
<p>Ocular manifestations were rare in the Bulgarian cohort (<a href="#B40" class="usa-link" aria-describedby="B40">40</a>–<a href="#B43" class="usa-link" aria-describedby="B43">43</a>). Decreased tear secretion was found in the majority of the cases, while amyloid deposition in the vitreous body and the lens, as well as bilateral ptosis were quite rare. Scalloped iris, glaucoma, and retinal vascular changes were not found in any of our 69 patients with ATTRv.</p>
<p>From our group treated patients with the TTR stabilizer for a period of 7 years 56% (84/150) remained stable, while in other 22.6% the neurological progression necessitated the treatment modification to TTR gene silencer (<a href="#B7" class="usa-link" aria-describedby="B7">7</a>). Those who progressed more rapidly or died, even on treatment, were diagnosed around 4 years after the clinical onset and had advanced restricted cardiomyopathy and heart failure.</p>
<p>The results from our study revealed that cardiac involvement has a great impact on prognosis as heart failure, sudden cardiac death, and cardio-embolic stroke are the main causes of death in the majority of the patients. In a previous study, we found a weak positive correlation between the NYHA class and the severity of neurological involvement in a cohort of patients with Glu89Gln mutation, i.e., a nonparallel progression of the polyneuropathy and the cardiomyopathy (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>). The efficacy of Tafamidis treatment depends to a great extent on the severity of organ involvement at the time of treatment initiation, but also on the rate of disease progression, which depends on the type of the mutation but also on not fully elucidated individual patients' characteristics.</p>
<p>The follow-up of asymptomatic carriers in our group was initiated 10 years prior to the mean age at onset, characteristic for each mutation in the <em>TTR</em> gene (<a href="#B22" class="usa-link" aria-describedby="B22">22</a>). In the last 3 years, more than half of these asymptomatic carriers transitioned to symptomatic (<a href="#B22" class="usa-link" aria-describedby="B22">22</a>), and subsequently therapy with TTR stabilizers was initiated at a very early stage.</p></section><section id="s5"><h2 class="pmc_sec_title">Conclusion</h2>
<p>Bulgarian patients with ATTRv display a mixed phenotype with some clinical peculiarities for each mutation, which should be considered when following up asymptomatic carriers of a specific gene defect. The screening programs of the high-risk patient population from the affected family or from the endemic region represent a potent tool for early diagnostic and timely treatment. The follow-up program for asymptomatic carriers has enabled us to initiate treatment as early as possible and, hopefully, with a better outcome for patients.</p></section><section id="s6"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></section><section id="s7"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The studies involving human participants were reviewed and approved by Medical University Sofia Institutional Review Board. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p></section><section id="s8"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>All authors contributed to manuscript preparation and critical review. All authors contributed to the article and approved the submitted version.</p></section><section id="conf1"><h2 class="pmc_sec_title">Conflict of Interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s9"><h2 class="pmc_sec_title">Publisher's Note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors wish to acknowledge Euro NMD, Pfizer for financing the project on “Following the asymptomatic carriers of mutations in TTR gene” and the TTR patients organization. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.</p></section><section id="s10"><h2 class="pmc_sec_title">Supplementary Material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fneur.2022.844595/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fneur.2022.844595/full#supplementary-material</a></p>
<section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/9024406/bin/Table_1.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.5KB, DOCX) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>Adams D, Koike H, Slama M, Coelho T. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol. (2019) 15:387–404. 10.1038/s41582-019-0210-4</cite> [<a href="https://doi.org/10.1038/s41582-019-0210-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31209302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Neurol.&amp;title=Hereditary%20transthyretin%20amyloidosis:%20a%20model%20of%20medical%20progress%20for%20a%20fatal%20disease&amp;author=D%20Adams&amp;author=H%20Koike&amp;author=M%20Slama&amp;author=T%20Coelho&amp;volume=15&amp;publication_year=2019&amp;pages=387-404&amp;pmid=31209302&amp;doi=10.1038/s41582-019-0210-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve. (2007) 36:411–23. 10.1002/mus.20821</cite> [<a href="https://doi.org/10.1002/mus.20821" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17554795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Muscle%20Nerve.&amp;title=The%20molecular%20biology%20and%20clinical%20features%20of%20amyloid%20neuropathy&amp;author=MD%20Benson&amp;author=JC%20Kincaid&amp;volume=36&amp;publication_year=2007&amp;pages=411-23&amp;pmid=17554795&amp;doi=10.1002/mus.20821&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, et al. Guideline of transthyretin related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. (2013) 8:31. 10.1186/1750-1172-8-31</cite> [<a href="https://doi.org/10.1186/1750-1172-8-31" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3584981/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23425518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J%20Rare%20Dis.&amp;title=Guideline%20of%20transthyretin%20related%20hereditary%20amyloidosis%20for%20clinicians&amp;author=Y%20Ando&amp;author=T%20Coelho&amp;author=JL%20Berk&amp;author=MW%20Cruz&amp;author=BG%20Ericzon&amp;volume=8&amp;publication_year=2013&amp;pages=31&amp;pmid=23425518&amp;doi=10.1186/1750-1172-8-31&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>Ohmori H, Ando Y, Makita Y, Onouchi Y, Nakajima T, Saraiva MJM, et al. Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy. J Med Genet. (2004) 41:e51. 10.1136/jmg.2003.014803</cite> [<a href="https://doi.org/10.1136/jmg.2003.014803" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1735751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15060127/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet.&amp;title=Common%20origin%20of%20the%20Val30Met%20mutation%20responsible%20for%20the%20amyloidogenic%20transthyretin%20type%20of%20familial%20amyloidotic%20polyneuropathy&amp;author=H%20Ohmori&amp;author=Y%20Ando&amp;author=Y%20Makita&amp;author=Y%20Onouchi&amp;author=T%20Nakajima&amp;volume=41&amp;publication_year=2004&amp;pages=e51&amp;pmid=15060127&amp;doi=10.1136/jmg.2003.014803&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>Parman Y, Adams D, Obici L, Guergueltcheva V, Suhr OB, Coelho T. European Network for TTR-FAP (ATTReuNET). Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol. (2016) 29:S3–13. 10.1097/WCO.0000000000000288</cite> [<a href="https://doi.org/10.1097/WCO.0000000000000288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4739317/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26734951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Neurol.&amp;title=European%20Network%20for%20TTR-FAP%20(ATTReuNET).%20Sixty%20years%20of%20transthyretin%20familial%20amyloid%20polyneuropathy%20(TTR-FAP)%20in%20Europe:%20where%20are%20we%20now?%20A%20European%20network%20approach%20to%20defining%20the%20epidemiology%20and%20management%20patterns%20for%20TTR-FAP&amp;author=Y%20Parman&amp;author=D%20Adams&amp;author=L%20Obici&amp;author=V%20Guergueltcheva&amp;author=OB%20Suhr&amp;volume=29&amp;publication_year=2016&amp;pages=S3-13&amp;pmid=26734951&amp;doi=10.1097/WCO.0000000000000288&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>Conceição I, Gonzalez-Duarte A, Obici L, Schmidt HHJ, Simoneau D, Ong ML, et al. “Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy. J Peripher Nerv Syst. (2016) 21:5–9. 10.1111/jns.12153</cite> [<a href="https://doi.org/10.1111/jns.12153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4788142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26663427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Peripher%20Nerv%20Syst.&amp;title=%E2%80%9CRed-flag%E2%80%9D%20symptom%20clusters%20in%20transthyretin%20familial%20amyloid%20polyneuropathy&amp;author=I%20Concei%C3%A7%C3%A3o&amp;author=A%20Gonzalez-Duarte&amp;author=L%20Obici&amp;author=HHJ%20Schmidt&amp;author=D%20Simoneau&amp;volume=21&amp;publication_year=2016&amp;pages=5-9&amp;pmid=26663427&amp;doi=10.1111/jns.12153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>Kapoor M, Rossor A, Laura M, Reilly MM. Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis. J Neuromuscul Dis. (2019) 6:189–99. 10.3233/JND-180371</cite> [<a href="https://doi.org/10.3233/JND-180371" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6598024/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30829617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuromuscul%20Dis.&amp;title=Clinical%20Presentation,%20Diagnosis%20and%20Treatment%20of%20TTR%20Amyloidosis&amp;author=M%20Kapoor&amp;author=A%20Rossor&amp;author=M%20Laura&amp;author=MM%20Reilly&amp;volume=6&amp;publication_year=2019&amp;pages=189-99&amp;pmid=30829617&amp;doi=10.3233/JND-180371&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>Gospodinova M, Sarafov S, Chamova T, Kirov A, Todorov T, Nakov R, et al. Tournev I. Cardiac involvement, morbidity and mortality in hereditary transthyretin amyloidosis because of pGlu89Gln mutation. J Cardiovasc Med (Hagerstown). (2020) 21:688–95. 10.2459/JCM.0000000000001036</cite> [<a href="https://doi.org/10.2459/JCM.0000000000001036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32740500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cardiovasc%20Med%20(Hagerstown).&amp;title=Tournev%20I.%20Cardiac%20involvement,%20morbidity%20and%20mortality%20in%20hereditary%20transthyretin%20amyloidosis%20because%20of%20pGlu89Gln%20mutation&amp;author=M%20Gospodinova&amp;author=S%20Sarafov&amp;author=T%20Chamova&amp;author=A%20Kirov&amp;author=T%20Todorov&amp;volume=21&amp;publication_year=2020&amp;pages=688-95&amp;pmid=32740500&amp;doi=10.2459/JCM.0000000000001036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>Nakov R, Nakov V, Gospodinova M, Todorov T, Todorova A, Chamova T, et al. Screening for hereditary transthyretin amyloidosis in Bulgaria. Med Pharm Rep. (2021) 94:S8–10. 10.15386/mpr-2218</cite> [<a href="https://doi.org/10.15386/mpr-2218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8411817/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34527899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med%20Pharm%20Rep.&amp;title=Screening%20for%20hereditary%20transthyretin%20amyloidosis%20in%20Bulgaria&amp;author=R%20Nakov&amp;author=V%20Nakov&amp;author=M%20Gospodinova&amp;author=T%20Todorov&amp;author=A%20Todorova&amp;volume=94&amp;publication_year=2021&amp;pages=S8-10&amp;pmid=34527899&amp;doi=10.15386/mpr-2218&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>Pavlova Z, Sarafov S, Todorov T, Kirov A, Chamova T, Gospodinova M, et al. Characterization of population genetic structure of hereditary transthyretin amyloidosis in Bulgaria. Amyloid. (2021) 28:219–25. 10.1080/13506129.2021.1935230</cite> [<a href="https://doi.org/10.1080/13506129.2021.1935230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34076545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Characterization%20of%20population%20genetic%20structure%20of%20hereditary%20transthyretin%20amyloidosis%20in%20Bulgaria&amp;author=Z%20Pavlova&amp;author=S%20Sarafov&amp;author=T%20Todorov&amp;author=A%20Kirov&amp;author=T%20Chamova&amp;volume=28&amp;publication_year=2021&amp;pages=219-25&amp;pmid=34076545&amp;doi=10.1080/13506129.2021.1935230&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Kirov A, Sarafov S, Pavlova Z, Todorov T, Chamova T, Gospodinova M, et al. Founder effect of the Glu89Gln TTR mutation in the Bulgarian population. Amyloid. (2019) 26:181–5. 10.1080/13506129.2019.1634539</cite> [<a href="https://doi.org/10.1080/13506129.2019.1634539" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31353960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Founder%20effect%20of%20the%20Glu89Gln%20TTR%20mutation%20in%20the%20Bulgarian%20population&amp;author=A%20Kirov&amp;author=S%20Sarafov&amp;author=Z%20Pavlova&amp;author=T%20Todorov&amp;author=T%20Chamova&amp;volume=26&amp;publication_year=2019&amp;pages=181-5&amp;pmid=31353960&amp;doi=10.1080/13506129.2019.1634539&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>Nakov R, Sarafov S, Nakov V, Gospodinova M, Ianiro G, Todorov T, et al. Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations. Medicine. (2020) 99:e19509. 10.1097/MD.0000000000019509</cite> [<a href="https://doi.org/10.1097/MD.0000000000019509" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7440347/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32176096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicine.&amp;title=Fecal%20calprotectin%20levels%20are%20elevated%20in%20transthyretin%20amyloidosis%20patients%20with%20gastrointestinal%20manifestations&amp;author=R%20Nakov&amp;author=S%20Sarafov&amp;author=V%20Nakov&amp;author=M%20Gospodinova&amp;author=G%20Ianiro&amp;volume=99&amp;publication_year=2020&amp;pages=e19509&amp;pmid=32176096&amp;doi=10.1097/MD.0000000000019509&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the rochester diabetic neuropathy study of healthy subjects. Neurology. (1995) 45:1115–21. 10.1212/WNL.45.6.1115</cite> [<a href="https://doi.org/10.1212/WNL.45.6.1115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7783874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology.&amp;title=Variables%20influencing%20neuropathic%20endpoints:%20the%20rochester%20diabetic%20neuropathy%20study%20of%20healthy%20subjects&amp;author=PJ%20Dyck&amp;author=WJ%20Litchy&amp;author=KA%20Lehman&amp;author=JL%20Hokanson&amp;author=PA%20Low&amp;volume=45&amp;publication_year=1995&amp;pages=1115-21&amp;pmid=7783874&amp;doi=10.1212/WNL.45.6.1115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant. (2007) 7:2597–604. 10.1111/j.1600-6143.2007.01969.x</cite> [<a href="https://doi.org/10.1111/j.1600-6143.2007.01969.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17868062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Transplant.&amp;title=Liver%20transplantation%20for%20familial%20amyloidotic%20polyneuropathy%20(FAP):%20a%20single-center%20experience%20over%2016%20years&amp;author=S%20Yamamoto&amp;author=HE%20Wilczek&amp;author=G%20Nowak&amp;author=M%20Larsson&amp;author=A%20Oksanen&amp;volume=7&amp;publication_year=2007&amp;pages=2597-604&amp;pmid=17868062&amp;doi=10.1111/j.1600-6143.2007.01969.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Zouari HG, Wing Tin S. Ng, Wahab A, Damy T, Lefaucheur JP. Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy. Eur J Neurol. (2019) 26:94–e10. 10.1111/ene.13774</cite> [<a href="https://doi.org/10.1111/ene.13774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30102818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Neurol.&amp;title=Assessment%20of%20autonomic%20innervation%20of%20the%20foot%20in%20familial%20amyloid%20polyneuropathy&amp;author=HG%20Zouari&amp;author=S.%20Ng%20Wing%20Tin&amp;author=A%20Wahab&amp;author=T%20Damy&amp;author=JP%20Lefaucheur&amp;volume=26&amp;publication_year=2019&amp;pages=94-e10&amp;pmid=30102818&amp;doi=10.1111/ene.13774&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Spitzer A, Lang E, Birklein F, Claus D, Neundorfe B. Cardiac autonomic involvement and peripheral nerve function in patients with diabetic neuropathy. Funct Neurol. (1997) 12:115–22. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9218965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Funct%20Neurol.&amp;title=Cardiac%20autonomic%20involvement%20and%20peripheral%20nerve%20function%20in%20patients%20with%20diabetic%20neuropathy&amp;author=A%20Spitzer&amp;author=E%20Lang&amp;author=F%20Birklein&amp;author=D%20Claus&amp;author=B%20Neundorfe&amp;volume=12&amp;publication_year=1997&amp;pages=115-22&amp;pmid=9218965&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol. (2005) 79:319–28. 10.1002/ajh.20381</cite> [<a href="https://doi.org/10.1002/ajh.20381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16044444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hematol.&amp;title=Definition%20of%20organ%20involvement%20and%20treatment%20response%20in%20immunoglobulin%20light%20chain%20amyloidosis%20(AL):%20a%20consensus%20opinion%20from%20the%2010th%20International%20Symposium%20on%20Amyloid%20and%20Amyloidosis&amp;author=MA%20Gertz&amp;author=R%20Comenzo&amp;author=RH%20Falk&amp;author=JP%20Fermand&amp;author=BP%20Hazenberg&amp;volume=79&amp;publication_year=2005&amp;pages=319-28&amp;pmid=16044444&amp;doi=10.1002/ajh.20381&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>Evangelista A, Flachskampf F, Lancellotti P, Badano L, Aguilar R, Monaghan M, et al. European association of echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr. (2008) 9:438–48. 10.1093/ejechocard/jen174</cite> [<a href="https://doi.org/10.1093/ejechocard/jen174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18579482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Echocardiogr.&amp;title=European%20association%20of%20echocardiography%20recommendations%20for%20standardization%20of%20performance,%20digital%20storage%20and%20reporting%20of%20echocardiographic%20studies&amp;author=A%20Evangelista&amp;author=F%20Flachskampf&amp;author=P%20Lancellotti&amp;author=L%20Badano&amp;author=R%20Aguilar&amp;volume=9&amp;publication_year=2008&amp;pages=438-48&amp;pmid=18579482&amp;doi=10.1093/ejechocard/jen174&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. American society of echocardiography's nomenclature and standards committee; task force on chamber quantification. Recommendations for chamber quantification. Eur J Echocardiogr. (2006) 7:79–108. 10.1016/j.euje.2005.12.014</cite> [<a href="https://doi.org/10.1016/j.euje.2005.12.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16458610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Echocardiogr.&amp;title=American%20society%20of%20echocardiography's%20nomenclature%20and%20standards%20committee;%20task%20force%20on%20chamber%20quantification.%20Recommendations%20for%20chamber%20quantification&amp;author=RM%20Lang&amp;author=M%20Bierig&amp;author=RB%20Devereux&amp;author=FA%20Flachskampf&amp;author=E%20Foster&amp;volume=7&amp;publication_year=2006&amp;pages=79-108&amp;pmid=16458610&amp;doi=10.1016/j.euje.2005.12.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovascular Imaging. (2016) 17:1321–60. 10.1093/ehjci/jew082</cite> [<a href="https://doi.org/10.1093/ehjci/jew082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27422899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J%20Cardiovascular%20Imaging.&amp;title=Recommendations%20for%20the%20evaluation%20of%20left%20ventricular%20diastolic%20function%20by%20echocardiography:%20an%20update%20from%20the%20American%20society%20of%20echocardiography%20and%20the%20European%20association%20of%20cardiovascular%20imaging&amp;author=SF%20Nagueh&amp;author=OA%20Smiseth&amp;author=CP%20Appleton&amp;author=BF%20Byrd&amp;author=H%20Dokainish&amp;volume=17&amp;publication_year=2016&amp;pages=1321-60&amp;pmid=27422899&amp;doi=10.1093/ehjci/jew082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>Nakov R, Sarafov S, Nakov V, Gospodinova M, Todorov T, Kirov A, et al. Transthyretin amyloidosis with gastrointestinal manifestation: a case report. J Gastrointestin Liver Dis. (2019) 28:359–61. 10.15403/jgld-422</cite> [<a href="https://doi.org/10.15403/jgld-422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31517333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Gastrointestin%20Liver%20Dis.&amp;title=Transthyretin%20amyloidosis%20with%20gastrointestinal%20manifestation:%20a%20case%20report&amp;author=R%20Nakov&amp;author=S%20Sarafov&amp;author=V%20Nakov&amp;author=M%20Gospodinova&amp;author=T%20Todorov&amp;volume=28&amp;publication_year=2019&amp;pages=359-61&amp;pmid=31517333&amp;doi=10.15403/jgld-422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>Conceição I, Damy T, Romero M, Galán L, Attarian S, Luigetti M, et al. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid. (2019) 26:3–9. 10.1080/13506129.2018.1556156</cite> [<a href="https://doi.org/10.1080/13506129.2018.1556156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30793974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Early%20diagnosis%20of%20ATTR%20amyloidosis%20through%20targeted%20follow-up%20of%20identified%20carriers%20of%20TTR%20gene%20mutations&amp;author=I%20Concei%C3%A7%C3%A3o&amp;author=T%20Damy&amp;author=M%20Romero&amp;author=L%20Gal%C3%A1n&amp;author=S%20Attarian&amp;volume=26&amp;publication_year=2019&amp;pages=3-9&amp;pmid=30793974&amp;doi=10.1080/13506129.2018.1556156&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>Sarafov S. Clinico-Genetic and Epidemiologic Research in Hereditary Amyotrophic Lateral Sclerosis and Transthyretin Amyloidosis in Bulgaria. (Ph.D. Thesis). Medical University of Sofia, Sofia, Bulgaria;  (2021).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Clinico-Genetic%20and%20Epidemiologic%20Research%20in%20Hereditary%20Amyotrophic%20Lateral%20Sclerosis%20and%20Transthyretin%20Amyloidosis%20in%20Bulgaria&amp;author=S%20Sarafov&amp;publication_year=2021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>Adams D, Ando Y, Beirão JM, Coelho T, Gertz MA, Gillmore JD, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. (2021) 268:2109–22. 10.1007/s00415-019-09688-0</cite> [<a href="https://doi.org/10.1007/s00415-019-09688-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8179912/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31907599/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurol.&amp;title=Expert%20consensus%20recommendations%20to%20improve%20diagnosis%20of%20ATTR%20amyloidosis%20with%20polyneuropathy&amp;author=D%20Adams&amp;author=Y%20Ando&amp;author=JM%20Beir%C3%A3o&amp;author=T%20Coelho&amp;author=MA%20Gertz&amp;volume=268&amp;publication_year=2021&amp;pages=2109-22&amp;pmid=31907599&amp;doi=10.1007/s00415-019-09688-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Tanaka F, et al. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid. (2011) 18:53–62. 10.3109/13506129.2011.565524</cite> [<a href="https://doi.org/10.3109/13506129.2011.565524" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21463231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Diagnosis%20of%20sporadic%20transthyretin%20Val30Met%20familial%20amyloid%20polyneuropathy:%20a%20practical%20analysis&amp;author=H%20Koike&amp;author=R%20Hashimoto&amp;author=M%20Tomita&amp;author=Y%20Kawagashira&amp;author=M%20Iijima&amp;volume=18&amp;publication_year=2011&amp;pages=53-62&amp;pmid=21463231&amp;doi=10.3109/13506129.2011.565524&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. (2020) 581:434–443
10.1530/ey.17.14.3</cite> [<a href="https://doi.org/10.1530/ey.17.14.3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7334197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32461654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature.&amp;title=The%20mutational%20constraint%20spectrum%20quantified%20from%20variation%20in%20141,456%20humans&amp;author=KJ%20Karczewski&amp;author=LC%20Francioli&amp;author=G%20Tiao&amp;author=BB%20Cummings&amp;author=J%20Alf%C3%B6ldi&amp;volume=581&amp;publication_year=2020&amp;pages=434-443&amp;pmid=32461654&amp;doi=10.1530/ey.17.14.3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>Almeida MR, Ferlini A, Forabosco A, Gawinowicz M, Costa PP, Salvi F, et al. Two transthyretin variants (TTR Ala-49 and TTR Gln-89) in two Sicilian kindreds with hereditary amyloidosis. Hum Mutat. (1992) 1:211–5. 10.1002/humu.1380010306</cite> [<a href="https://doi.org/10.1002/humu.1380010306" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1301926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat.&amp;title=Two%20transthyretin%20variants%20(TTR%20Ala-49%20and%20TTR%20Gln-89)%20in%20two%20Sicilian%20kindreds%20with%20hereditary%20amyloidosis&amp;author=MR%20Almeida&amp;author=A%20Ferlini&amp;author=A%20Forabosco&amp;author=M%20Gawinowicz&amp;author=PP%20Costa&amp;volume=1&amp;publication_year=1992&amp;pages=211-5&amp;pmid=1301926&amp;doi=10.1002/humu.1380010306&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>Gentile L, Tournev I, Amass L, Chapman D, Mazzeo A, THAOS investigators. Phenotypic differences of Glu89Gln genotype in ATTR amyloidosis from endemic Loci: update from THAOS. Cardiol Ther. (2021) 10:481–90. 10.1007/s40119-021-00226-6</cite> [<a href="https://doi.org/10.1007/s40119-021-00226-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8555027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34148211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiol%20Ther.&amp;title=Phenotypic%20differences%20of%20Glu89Gln%20genotype%20in%20ATTR%20amyloidosis%20from%20endemic%20Loci:%20update%20from%20THAOS&amp;author=L%20Gentile&amp;author=I%20Tournev&amp;author=L%20Amass&amp;author=D%20Chapman&amp;author=A%20Mazzeo&amp;volume=10&amp;publication_year=2021&amp;pages=481-90&amp;pmid=34148211&amp;doi=10.1007/s40119-021-00226-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>Conceição I, De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve. (2007) 35:116–8. 10.1002/mus.20644</cite> [<a href="https://doi.org/10.1002/mus.20644" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16969832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Muscle%20Nerve.&amp;title=Clinical%20variability%20in%20type%20I%20familial%20amyloid%20polyneuropathy%20(Val30Met):%20comparison%20between%20late-%20and%20early-onset%20cases%20in%20Portugal&amp;author=I%20Concei%C3%A7%C3%A3o&amp;author=M%20De%20Carvalho&amp;volume=35&amp;publication_year=2007&amp;pages=116-8&amp;pmid=16969832&amp;doi=10.1002/mus.20644&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>Hellman U, Alarcon F, Lundgren HE, Suhr OB, Bonaiti-Pellie C, Plante-Bordeneuve V. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid. (2008) 15:181–6. 10.1080/13506120802193720</cite> [<a href="https://doi.org/10.1080/13506120802193720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2738945/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18925456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Heterogeneity%20of%20penetrance%20in%20familial%20amyloid%20polyneuropathy,%20ATTR%20Val30Met,%20in%20the%20Swedish%20population&amp;author=U%20Hellman&amp;author=F%20Alarcon&amp;author=HE%20Lundgren&amp;author=OB%20Suhr&amp;author=C%20Bonaiti-Pellie&amp;volume=15&amp;publication_year=2008&amp;pages=181-6&amp;pmid=18925456&amp;doi=10.1080/13506120802193720&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>Planté-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology. (2007) 69:693–8. 10.1212/01.wnl.0000267338.45673.f4</cite> [<a href="https://doi.org/10.1212/01.wnl.0000267338.45673.f4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17698792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology.&amp;title=Diagnostic%20pitfalls%20in%20sporadic%20transthyretin%20familial%20amyloid%20polyneuropathy%20(TTR-FAP)&amp;author=V%20Plant%C3%A9-Bordeneuve&amp;author=A%20Ferreira&amp;author=T%20Lalu&amp;author=C%20Zaros&amp;author=C%20Lacroix&amp;volume=69&amp;publication_year=2007&amp;pages=693-8&amp;pmid=17698792&amp;doi=10.1212/01.wnl.0000267338.45673.f4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>Haagsma EB, Hawkins PN, Benson MD, Lachmann HJ, Bybee A, Hazenberg BP. Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish families. Amyloid. (2004) 11:44–9. 10.1080/13506120410001682578</cite> [<a href="https://doi.org/10.1080/13506120410001682578" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15185498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Familial%20amyloidotic%20polyneuropathy%20with%20severe%20renal%20involvement%20in%20association%20with%20transthyretin%20Gly47Glu%20in%20Dutch,%20British%20and%20American-Finnish%20families&amp;author=EB%20Haagsma&amp;author=PN%20Hawkins&amp;author=MD%20Benson&amp;author=HJ%20Lachmann&amp;author=A%20Bybee&amp;volume=11&amp;publication_year=2004&amp;pages=44-9&amp;pmid=15185498&amp;doi=10.1080/13506120410001682578&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>Durmuş-Tekçe H, Matur Z, Mert Atmaca M, Poda M, Çakar A, Hidir Ulaş Ü, et al. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Neuromuscul Disord. (2016) 26:441–6. 10.1016/j.nmd.2016.04.013</cite> [<a href="https://doi.org/10.1016/j.nmd.2016.04.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27238058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuromuscul%20Disord.&amp;title=Genotypic%20and%20phenotypic%20presentation%20of%20transthyretin-related%20familial%20amyloid%20polyneuropathy%20(TTR-FAP)%20in%20Turkey&amp;author=H%20Durmu%C5%9F-Tek%C3%A7e&amp;author=Z%20Matur&amp;author=M%20Mert%20Atmaca&amp;author=M%20Poda&amp;author=A%20%C3%87akar&amp;volume=26&amp;publication_year=2016&amp;pages=441-6&amp;pmid=27238058&amp;doi=10.1016/j.nmd.2016.04.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>Rapezzi C, Perugini E, Salvi F, Riva L, Cooke RMT, Ferlini A, et al. Phenotypic and genotypic heterogenicity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies?
Amyloid. (2006) 13:143–53. 10.1080/13506120600877136</cite> [<a href="https://doi.org/10.1080/13506120600877136" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17062380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Phenotypic%20and%20genotypic%20heterogenicity%20in%20transthyretin-related%20cardiac%20amyloidosis:%20Towards%20tailoring%20of%20therapeutic%20strategies?&amp;author=C%20Rapezzi&amp;author=E%20Perugini&amp;author=F%20Salvi&amp;author=L%20Riva&amp;author=RMT%20Cooke&amp;volume=13&amp;publication_year=2006&amp;pages=143-53&amp;pmid=17062380&amp;doi=10.1080/13506120600877136&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>Iorio A, De Angelis F, Di Girolamo M, Luigetti M, Pradotto LG, Mazzeo A, et al. Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis. BMC Genomics. (2017) 18:254. 10.1186/s12864-017-3646-1</cite> [<a href="https://doi.org/10.1186/s12864-017-3646-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5364715/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28335735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Genomics.&amp;title=Population%20diversity%20of%20the%20genetically%20determined%20TTR%20expression%20in%20human%20tissues%20and%20its%20implications%20in%20TTR%20amyloidosis&amp;author=A%20Iorio&amp;author=F%20De%20Angelis&amp;author=M%20Di%20Girolamo&amp;author=M%20Luigetti&amp;author=LG%20Pradotto&amp;volume=18&amp;publication_year=2017&amp;pages=254&amp;pmid=28335735&amp;doi=10.1186/s12864-017-3646-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>Polimanti R, Di Girolamo M, Manfellotto D., Fuciarelli M. Functional variation of the transthyretin gene among human populations and its correlation with amyloidosis phenotypes. Amyloid. (2013) 20:256–62. 10.3109/13506129.2013.844689</cite> [<a href="https://doi.org/10.3109/13506129.2013.844689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24111657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Functional%20variation%20of%20the%20transthyretin%20gene%20among%20human%20populations%20and%20its%20correlation%20with%20amyloidosis%20phenotypes&amp;author=R%20Polimanti&amp;author=M%20Di%20Girolamo&amp;author=D.%20Manfellotto&amp;author=M%20Fuciarelli&amp;volume=20&amp;publication_year=2013&amp;pages=256-62&amp;pmid=24111657&amp;doi=10.3109/13506129.2013.844689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>Alves-Ferreira M, Coelho T, Santos D, Sequeiros J, Alonso I, Sousa A, et al. Trans-acting factor may modify age at onset in familial amyloid polyneuropathy ATTRV30M in Portugal. Mol Neurobiol. (2018) 55:3676. 10.1007/s12035-017-0593-4</cite> [<a href="https://doi.org/10.1007/s12035-017-0593-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28527106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Neurobiol.&amp;title=Trans-acting%20factor%20may%20modify%20age%20at%20onset%20in%20familial%20amyloid%20polyneuropathy%20ATTRV30M%20in%20Portugal&amp;author=M%20Alves-Ferreira&amp;author=T%20Coelho&amp;author=D%20Santos&amp;author=J%20Sequeiros&amp;author=I%20Alonso&amp;volume=55&amp;publication_year=2018&amp;pages=3676&amp;pmid=28527106&amp;doi=10.1007/s12035-017-0593-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>Yordanova I, Pavlova Z, Kirov A, Todorov T, Alexiev A, Sarafov S, et al. Monoallelic expression of the TTR gene as a contributor to the age at onset and penetrance of TTR-related amyloidosis. Gene. (2019) 705:16–21. 10.1016/j.gene.2019.04.030</cite> [<a href="https://doi.org/10.1016/j.gene.2019.04.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30981840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gene.&amp;title=Monoallelic%20expression%20of%20the%20TTR%20gene%20as%20a%20contributor%20to%20the%20age%20at%20onset%20and%20penetrance%20of%20TTR-related%20amyloidosis&amp;author=I%20Yordanova&amp;author=Z%20Pavlova&amp;author=A%20Kirov&amp;author=T%20Todorov&amp;author=A%20Alexiev&amp;volume=705&amp;publication_year=2019&amp;pages=16-21&amp;pmid=30981840&amp;doi=10.1016/j.gene.2019.04.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>Soares ML, Coelho T, Sousa A, Batalov S, Conceição I, Sales-Luís ML, et al. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease. Hum Mol Genet. (2005) 14:543–53. 10.1093/hmg/ddi051</cite> [<a href="https://doi.org/10.1093/hmg/ddi051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15649951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mol%20Genet.&amp;title=Susceptibility%20and%20modifier%20genes%20in%20Portuguese%20transthyretin%20V30M%20amyloid%20polyneuropathy:%20complexity%20in%20a%20single-gene%20disease&amp;author=ML%20Soares&amp;author=T%20Coelho&amp;author=A%20Sousa&amp;author=S%20Batalov&amp;author=I%20Concei%C3%A7%C3%A3o&amp;volume=14&amp;publication_year=2005&amp;pages=543-53&amp;pmid=15649951&amp;doi=10.1093/hmg/ddi051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>Ando E, Ando Y, Okamura R, Ochino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol. (1997) 81:295–8. 10.1136/bjo.81.4.295</cite> [<a href="https://doi.org/10.1136/bjo.81.4.295" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1722164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9215058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Ophthalmol&amp;title=Ocular%20manifestations%20of%20familial%20amyloidotic%20polyneuropathy%20type%20I:%20long-term%20follow%20up&amp;author=E%20Ando&amp;author=Y%20Ando&amp;author=R%20Okamura&amp;author=M%20Ochino&amp;author=M%20Ando&amp;volume=81&amp;publication_year=1997&amp;pages=295-8&amp;pmid=9215058&amp;doi=10.1136/bjo.81.4.295&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>Beira~o NM, Matos ME, Meneres MJ, Beira~o IM, Costa PP, Torres PA. Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients. Amyloid. (2012) 19:146–51. 10.3109/13506129.2012.710669</cite> [<a href="https://doi.org/10.3109/13506129.2012.710669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22856884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Vitreous%20surgery%20impact%20in%20glaucoma%20development%20in%20liver%20transplanted%20familial%20amyloidosis%20ATTR%20V30M%20Portuguese%20patients&amp;author=NM%20Beira~o&amp;author=ME%20Matos&amp;author=MJ%20Meneres&amp;author=IM%20Beira~o&amp;author=PP%20Costa&amp;volume=19&amp;publication_year=2012&amp;pages=146-51&amp;pmid=22856884&amp;doi=10.3109/13506129.2012.710669&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>Beira~o JM, Malheiro J, Lemos C, Beira~o I, Costa P, Torres P. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases. Amyloid. (2015) 22:117–122. 10.3109/13506129.2015.1015678</cite> [<a href="https://doi.org/10.3109/13506129.2015.1015678" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4673564/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26096568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Ophthalmological%20manifestations%20in%20hereditary%20transthyretin%20(ATTR%20V30M)%20carriers:%20a%20review%20of%20513%20cases&amp;author=JM%20Beira~o&amp;author=J%20Malheiro&amp;author=C%20Lemos&amp;author=I%20Beira~o&amp;author=P%20Costa&amp;volume=22&amp;publication_year=2015&amp;pages=117-122&amp;pmid=26096568&amp;doi=10.3109/13506129.2015.1015678&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>Tong JY, Juniat V, McKelvie PA, O'Donnell BA, Hardy TG, McNab AA., Selva D. Clinical and radiological features of intramuscular orbital amyloidosis: a case series and literature review. Ophthalmic Plast Reconstr Surg. (2021) 20:1–8. 10.1097/IOP.0000000000002061</cite> [<a href="https://doi.org/10.1097/IOP.0000000000002061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34516528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmic%20Plast%20Reconstr%20Surg.&amp;title=Clinical%20and%20radiological%20features%20of%20intramuscular%20orbital%20amyloidosis:%20a%20case%20series%20and%20literature%20review&amp;author=JY%20Tong&amp;author=V%20Juniat&amp;author=PA%20McKelvie&amp;author=BA%20O'Donnell&amp;author=TG%20Hardy&amp;volume=20&amp;publication_year=2021&amp;pages=1-8&amp;pmid=34516528&amp;doi=10.1097/IOP.0000000000002061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9024406/bin/Table_1.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.5KB, DOCX) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Neurology are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fneur.2022.844595"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fneur-13-844595.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (436.7 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9024406/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9024406/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9024406%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024406/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9024406/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9024406/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/35463150/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9024406/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/35463150/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9024406/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9024406/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="VFBrGpX5Hh0Ap0VRBkr8sqcJG0fbU7f3Woo89alhEDf6JtecPywOg4EjrOvLxHWH">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
